<
Anti -bird flu new medicine Paramov is certified and put into production without a timetable
Release time: 2013-05-02 & nbsp & nbsp & nbsp Source: Anonymous

Reporter learned from Stake Sports BettingStake Sports BettingHunan Narut Platinum Biopharmaceutical Co., Ltd.,In early April, the company's anti -bird flu new drug Parami has passed GMP (drug production management quality specification) certification,But there is no production schedule。
 
Early last month,To cope with people infected with H7N9 bird flu epidemic,The State Food and Drug Administration and the Pharmaceutical Review Center quickly deployed and approved the listing of new drugs independently developed by China。According to the relevant procedures,After Paramine passed GMP certification,can be put into production。
 
but,Hunan Nonferrous Kay Platinum Relevant person in charge told reporters on the 1st,When Paramovy is put into production is planning,It is necessary to study according to market conditions。
 
It is understood,Paramine is the raw medicine for anti -avian influenza My stake betting appdrugs,It must be used Stake Sports Bettingfor human body,It is also necessary to make preparations & mdash; & mdash; sodium chloride Paramine injection。According to the State Administration of Food and Drug Administration,Hunan Nonferrous Kenjie is approved by the Paramile Sanshura Materials,Guangzhou Nanxin Pharmaceutical Co., Ltd. was approved by the production of sodium chloride injection of Paramine Sanshui compound。and Guangzhou Nanxin Pharmaceutical is the holding subsidiary of Hunan Non -Platinum Platinum Platinum。That is to say,Hunan Nonferrous Kenaco Platinum is actually the first pharmaceutical company in China to produce Paramine。
 
Clinical Studies indicate,Paramine injection solution can effectively fight the influenza virus of Naisawee,and the dosage form is injection,Adaptation to patients with influenza hazardous patients and stake betting apppatients with poor efficacy stake online sports bettingof other neurophanase inhibitors。The listing of this drug will provide new treatment methods for patients with H7N9 avian influenza。
 
Paramine was developed from 2005 by the Institute of Poison and Drugs of the Academy of Military Medical Sciences,Complete clinical research in 2011,In December 2012, it passed the technical review of the drug review center for approval。Hunan Nonferrous Kenjie introduced this project in 2009,Start trying production at Liuyang Pharmaceutical Park。